The Top 10 Psychedelic Science Studies Of 2022
collaborative practice
Re-Imagining Psychosis with Filmmaker Rebeccah Love
A Revolution Wobbles: Will Norway’s “Medication-Free” Hospital Survive?
First, We Make the Beast Beautiful: A new story about anxiety
The experiences of 585 people when they tried to withdraw from antipsychotic drugs
This research paper from Prof. John Read has been published in Addictive Behaviors Reports. The abstract says: “Introduction Many recipients of antipsychotic drugs try to stop taking them, primarily because of distressing adverse effects. Little research has been undertaken into the withdrawal…
Read more
Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial
This research paper has been published in eClinicalMedicine. The summary says: “Background Psilocybin has been suggested as a novel, rapid-acting treatment for depression. Two consecutive doses have been shown to markedly decrease symptom severity in an open-label setting or when compared to…
Read more
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data
The Effectiveness of an Intensive Inpatient Psychotherapy Program for Chronic Depression: A naturalistic comparison with wait list
This paper has been published by BMC Psychiatry. The abstract says: “Background Patients with chronic depression (CD) typically have an early symptom onset, more psychiatric comorbidities, more treatment attempts, and more frequent and longer inpatient hospitalizations than patients with major depressive…
Read more
How to make Mental Health Act interviews more dialogical
This blog post by Rob Manchester has been published on the website of Mad in the UK. Originally published on The Critical AMHP [AMHP: Approved Mental Health Professional) site], it begins: “I set out the case for this in an article last year entitled ‘It’s time…
Read more
‘When life was unbearable, horses helped us through’
